OpenJournalRank
Compare

Journal rankings · indicator year 2025

Choose a field to open its ranking, or a journal to find its row in its subfield’s list.

Subfield ranking · 2025

Endocrinology, Diabetes and Metabolism journal rankings 2025

152 ranked journals · Subfield in Medicine

Endocrinology, Diabetes and Metabolism has 152 ranked journals in 2025. The median journal has an OJR of 0.87, below the world average of 1.00, down 0.05 on 2024; Q1 starts at OJR 1.36. The two highest-scoring journals with stable ranks are Endocrine Reviews and The Lancet Diabetes & Endocrinology: each is likely ranked within the top 3.

Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.

Ranked journals

Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.

152
3% of Medicine
Median OJR

The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.

The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.

The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.

0.87-0.05 vs 2024
This subfieldAll 0.78World 1.00
Open-access journals

Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.

49%
All fields: 38%
Median listed APC

Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.

$3,310
Median positive listed APC: $3,310 among 88 journals. Another 2 list $0; 62 have no known price. All fields: $3,200.

Subfields of Medicine (42)

Show all 42 subfields

152 ranked journals

Filters

Quartile

Quartiles split the ranked journals of the list you are viewing into four equal groups by OJR. Q1 is the top quarter and Q4 the bottom quarter.

They are computed within the list on screen, so a journal can be Q1 in its subfield and Q2 in the global ranking.

Access
APC (list price)
Loading every ranked journal in this list…
Endocrinology, Diabetes and Metabolism ranking, 2025

Rank is the position by OJR within the list on screen; 1 is the highest.

The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different.

OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields.

The badge is the journal’s quartile in this list.

OJR

Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field.

▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor.

Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked.

Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal.

List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed.

The line is the journal’s OJR from 2016 to 2025.

A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change.

Compare
Rank 1; likely between #1 and #1 of 152Endocrine ReviewsOxford University Press · United States
10.95Q126.30 0.11 down from 20249775%$3,750
Rank 2; likely between #2 and #3 of 152The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands
6.57Q114.49 3.74 down from 202446039%$7,280
Rank 3; likely between #2 and #4 of 152Diabetes CareAmerican Diabetes Association · United States
5.34Q116.28 2.29 up from 20241,27086%—
Rank 4; likely between #3 and #5 of 152Cardiovascular DiabetologyOABioMed Central · United Kingdom
4.39Q115.86 4.29 up from 20241,073100%$4,290Rising vs field, 2022–25
Rank 5; likely between #2 and #18 of 152Endocrine PathologySpringer Science+Business Media · United States
3.98Q14.22 10.58 down from 202412966%$3,190Rising vs field, 2022–25
Rank 6; likely between #5 and #7 of 152DiabetologiaSpringer Science+Business Media · Germany
3.52Q19.89 0.30 down from 202463274%$3,490Rising vs field, 2022–25
Rank 7; likely between #6 and #11 of 152Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands
2.86Q19.74 0.13 up from 202422063%$5,590
Rank 8; likely between #5 and #16 of 152Current Diabetes ReportsSpringer Science+Business Media · United States
2.75Q18.28 0.63 up from 202412250%$4,890
Rank 9; likely between #6 and #13 of 152Journal of Internal MedicineWiley · United Kingdom
2.62Q16.09 2.10 down from 202439980%$4,780
Rank 10; likely between #7 and #14 of 152Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom
2.58Q16.30 0.62 down from 202416449%$4,450
Rank 11; likely between #7 and #16 of 152Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea
2.53Q16.78 0.15 down from 2024285100%$500Rising vs field, 2022–25
Rank 12; likely between #6 and #29 of 152Therapeutic Advances in Endocrinology and MetabolismOASAGE Publishing · United Kingdom
2.28Q18.49 3.50 up from 2024122100%$2,650
Rank 13; likely between #8 and #22 of 152Diabetes/Metabolism Research and ReviewsWiley · United Kingdom
2.22Q18.84 2.21 up from 202431178%$4,780
Rank 14; likely between #12 and #18 of 152Lipids in Health and DiseaseOABioMed Central · United Kingdom
2.11Q17.00 2.49 up from 2024771100%$2,990Rising vs field, 2022–25
Rank 15; likely between #10 and #28 of 152European Journal of EndocrinologyOxford University Press · United Kingdom
2.01Q16.85 1.23 up from 202448269%$4,292
Rank 16; likely between #9 and #33 of 152Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States
1.98Q14.91 0.20 up from 202415813%$3,540
Rank 17; likely between #11 and #36 of 152Pediatric DiabetesWiley · Denmark
1.89Q12.12 4.25 down from 202422699%$2,740Rising vs field, 2022–25
Rank 18; likely between #15 and #27 of 152Diabetes Obesity and MetabolismWiley · United Kingdom
1.84Q15.68 0.21 up from 20241,43369%$5,380
Rank 19; likely between #16 and #27 of 152The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States
1.81Q15.39 0.23 up from 20242,15257%$3,750
Rank 20; likely between #13 and #34 of 152Diabetes & MetabolismElsevier BV · Netherlands
1.80Q15.20 0.42 up from 202418035%$4,490
Rank 21; likely between #12 and #38 of 152Journal of EndocrinologyBioscientifica · United Kingdom
1.79Q15.53 1.83 up from 202420232%—
Rank 22; likely between #15 and #29 of 152Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States
1.78Q16.92 0.78 up from 202441348%—
Rank 23; likely between #18 and #26 of 152Frontiers in EndocrinologyOAFrontiers Media · Switzerland
1.77Q16.02 0.74 up from 20248,698100%$3,801
Rank 24; likely between #12 and #40 of 152La Presse MédicaleElsevier BV · France
1.74Q15.00 1.60 up from 202410637%$2,320
Rank 25; likely between #16 and #31 of 152BMJ Open Diabetes Research & CareOABMJ · United Kingdom
1.74Q14.98 0.20 up from 2024361100%$3,000
Rank 26; likely between #15 and #36 of 152World Journal of DiabetesOAHong Kong SAR China
1.70Q14.43 1.02 down from 2024477100%—
Rank 27; likely between #17 and #33 of 152ThyroidMary Ann Liebert, Inc. · United States
1.68Q15.83 0.14 down from 202447234%—
Rank 28; likely between #13 and #52 of 152touchREVIEWS in EndocrinologyOATouch Medical Media · United Kingdom
1.62Q15.41 1.34 up from 202478100%—
Rank 29; likely between #13 and #49 of 152European Thyroid JournalOAKarger Publishers · Switzerland
1.61Q15.09 0.31 up from 2024215100%—
Rank 30; likely between #18 and #46 of 152Journal of DiabetesOAWiley · Australia
1.53Q15.05 1.60 up from 2024349100%$3,000Rising vs field, 2022–25
Rank 31; likely between #25 and #37 of 152Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom
1.51Q15.28 0.68 up from 2024749100%$2,890
Rank 32; likely between #25 and #46 of 152Endocrinology and MetabolismOAAcademya Publishing Co. · South Korea
1.45Q14.61 0.40 up from 2024301100%—
Rank 33; likely between #28 and #43 of 152MaturitasElsevier BV · Netherlands
1.42Q14.46 0.54 up from 202444020%$4,390
Rank 34; likely between #25 and #52 of 152JMIR DiabetesOACanada
1.41Q13.55 0.08 down from 2024118100%$1,873
Rank 35; likely between #22 and #58 of 152ClimactericTaylor & Francis · United Kingdom
1.40Q14.09 0.74 up from 202421644%—
Rank 36; likely between #19 and #62 of 152Endocrine PracticeElsevier BV · United States
1.38Q14.07 0.69 down from 202448924%$3,480
Rank 37; likely between #20 and #70 of 152Journal of Clinical & Translational EndocrinologyOAElsevier BV · Netherlands
1.36Q14.57 2.15 up from 202484100%$3,500
Rank 38; likely between #30 and #47 of 152Diabetes Research and Clinical PracticeElsevier BV · Netherlands
1.36Q14.06 0.43 up from 20241,19053%$4,410
Rank 39; likely between #27 and #59 of 152Endocrine Related CancerBioscientifica · United Kingdom
1.32Q23.77 1.07 down from 202422042%—
Rank 40; likely between #32 and #49 of 152Journal of Endocrinological InvestigationSpringer Science+Business Media · Italy
1.32Q24.24 0.51 up from 202476740%$4,790Falling vs field, 2022–25
Rank 41; likely between #29 and #55 of 152BMC Endocrine DisordersOABioMed Central · United Kingdom
1.31Q24.13 0.07 up from 2024882100%$3,190
Rank 42; likely between #23 and #75 of 152Clinical Diabetes and EndocrinologyOABioMed Central · United Kingdom
1.28Q23.98 1.32 up from 202469—$2,290
Rank 43; likely between #33 and #55 of 152Journal of Diabetes Science and TechnologySAGE Publishing · United States
1.28Q23.88 0.64 up from 202448298%$3,900
Rank 44; likely between #35 and #56 of 152Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom
1.27Q23.84 0.10 down from 2024347100%$2,760
Rank 45; likely between #32 and #64 of 152Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom
1.26Q23.72 0.67 up from 20241499%—
Rank 46; likely between #38 and #61 of 152Diabetes TherapyOAAdis, Springer Healthcare · United Kingdom
1.20Q24.65 1.68 up from 2024443100%$7,400
Rank 47; likely between #40 and #58 of 152Diabetes Metabolic Syndrome and ObesityOADove Medical Press · New Zealand
1.19Q23.62 0.42 up from 20241,132100%$2,836
Rank 48; likely between #38 and #62 of 152Journal of the Endocrine SocietyOAEndocrine Society · United States
1.19Q23.60 0.45 up from 2024573100%$3,255
Rank 49; likely between #42 and #60 of 152Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy
1.18Q23.85 0.30 up from 202489739%$3,000
Rank 50; likely between #32 and #75 of 152Frontiers in Clinical Diabetes and HealthcareOAFrontiers Media · Switzerland
1.15Q23.89 1.20 up from 2024182100%$2,353

The endpoints below each rank show its likely range. How rank ranges are calculated

Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.

39 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.

Rising journals

At a glance

Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated

Ranked journals
152
Window papers (baseline)
87,039 +9.1% from indicator year 2022
Median OJR
0.870 -2.3% from indicator year 2022
Rising journals (2025)
11

Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.

Category by indicator year
MeasureYear series20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025
Ranked journals48515760657078848995101111124132136141151156162168161163159159157152
Window papers (baseline)21,85724,17125,80627,52127,88030,06932,73236,73840,74046,75250,54053,88854,29056,10358,42461,71564,39366,58168,39170,38572,72975,89479,75082,00083,56087,039
Median OJR0.500.650.690.770.710.810.840.940.910.931.010.9590.980.8680.970.9570.9510.8930.9500.860.9540.88960.89030.91700.91650.870

How to read these rankings

OJR, the OpenJournalRank Indicator
A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
Quartiles
Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
Impact factor (2-year)
Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
Rank ranges
Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.